Skip to main navigation
Skip to search
Skip to main content
RSU Home
Log in
Link opens in a new tab
Search content at RSU
Home
Research units
Profiles
Publications
Projects
Datasets
Activities
Research Infrastructure
Prizes
Press/Media
Impacts
Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
Kristīne Ivanova
(Corresponding Author)
,
Maksims Zolovs
, Kaj Blennow
, Henrik Zetterberg
,
Nataļja Kurjāne
,
Viktorija Ķēniņa
Statistics Unit
Department of Biology and Microbiology
Institute of Oncology and Molecular Genetics
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
2
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Glial Fibrillary Acidic Protein
100%
Antiganglioside Antibodies
66%
Growth Differentiation Factor
66%
Myelin-Associated Glycoprotein
66%
GM1
33%
Light Chain
33%
Autoimmunity
33%
FGF21
33%
Nerve Conduction Study
33%
Diagnostic Biomarker
33%
Medicine and Dentistry
Biological Marker
100%
Polyneuropathy
100%
Systemic Scleroderma
100%
Glial Fibrillary Acidic Protein
27%
Growth Differentiation Factor 15
18%
Myelin Associated Glycoprotein
18%
Peripheral Nerve
18%
Nerve Conduction Study
9%
Light Chain
9%
Effect Size
9%
Sequela
9%
FGF21
9%
Autoimmunity
9%
Autoimmune Disease
9%
Ganglioside Antibody
9%
Ganglioside GQ 1b Antibody
9%
Ganglioside GM1 Antibody
9%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Biological Marker
100%
Polyneuropathy
100%
Glial Fibrillary Acidic Protein
27%
Growth Differentiation Factor 15
18%
Myelin Associated Glycoprotein
18%
Autoimmune Disease
9%
Inflammation
9%
Fibroblast Growth Factor 21
9%
Ganglioside GQ 1b Antibody
9%
Ganglioside Antibody
9%
Ganglioside GM1 Antibody
9%
Neuroscience
Polyneuropathy
100%
Glial Fibrillary Acidic Protein
33%
Peripheral Nerve
22%
Growth Differentiation Factor 15
22%
Myelin Associated Glycoprotein
22%
Nerve Conduction Study
11%
Autoimmune Disease
11%
Fibroblast Growth Factor 21
11%
Light Chain
11%
Ganglioside GQ 1b Antibody
11%
Ganglioside Antibody
11%
Ganglioside GM1 Antibody
11%
Immunology and Microbiology
Systemic Scleroderma
100%
Growth Differentiation Factor 15
18%
Antiganglioside Antibodies
18%
Myelin-Associated Glycoprotein
18%
Peripheral Nerve
18%
Autoimmunity
9%
Fibroblast Growth Factor 21
9%
Autoimmune Disease
9%
Light Chain
9%